Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
50 participants
INTERVENTIONAL
2019-06-01
2019-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block
NCT06899841
The Efficacy of Adding Dexmedetomidine Perineurally to Bupivacaine in Ultrasound Guided Fascia Iliaca Block Versus Intravenously Infused Dexmedetomidine on Hemodynamic Stability Intraoperatively and Postoperative Analgesia Following Hip Arthroscopy
NCT04917029
Systemic Versus Local Dexmedetomidine as An Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Block
NCT06386770
Comparison of Efficacy of Bupivacaine in Supraclavicular Block With or Without Dexmedetomidine
NCT05991375
Dexmedetomedine Infusion Versus Fentanyl Infusion for Donor Anlgesia During Living Donor Hepatectomy
NCT02531529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Patients received ultrasound guided supraclavicular block with 40 ml of Articaine hydrochloride 2%
Articaine
Vial
Group AD
Patients received ultrasound guided supraclavicular block with 40 ml articaine 2% mixed with dexmedetomidine (1 µg/kg).
Articaine
Vial
Dexmedetomidine
Vial
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Articaine
Vial
Dexmedetomidine
Vial
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Infection at the site of needle insertion.
* Those having international normalized ratio more than 1.5.
* Coagulopathy.
* Neuromuscular, or severe hepatic or severe pulmonary disease.
* Those having epilepsy.
* Patients who refused to participate.
25 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
simon Halim Armanious
Simon Halim, MD S. Armanious
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Galal Mo Professor, Doctor
Role: STUDY_DIRECTOR
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University hosptal
Cairo, Abbasya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Armanious SH, Abdelhameed GA. Articaine and Dexmedetomidine - Supplemented Articaine for Arteriovenous Fistula Creation under Ultrasound-guided Supraclavicular Block. Anesth Essays Res. 2020 Apr-Jun;14(2):248-252. doi: 10.4103/aer.AER_147_19. Epub 2020 Oct 12.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Articaine
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.